Raj K. Puri is Chief Regulatory Officer of IOVANCE BIOTHERAPEUTICS, INC.. Currently has a direct ownership of 209,854 shares of IOVA, which is worth approximately $365,145. The most recent transaction as insider was on Jun 02, 2025, when has been sold 2,467 shares (Common Stock) at a price of $1.76 per share, resulting in proceeds of $4,341. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 210K
4.27% 3M change
n/a 12M change
Total Value Held $365,145

Raj K. Puri Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 02 2025
SELL
Payment of exercise price or tax liability
$4,341 $1.76 p/Share
2,467 Reduced 1.16%
209,854 Common Stock
Jun 02 2025
BUY
Exercise of conversion of derivative security
-
5,469 Added 2.51%
212,321 Common Stock
May 23 2025
BUY
Open market or private purchase
$9,744 $1.74 p/Share
5,600 Added 2.64%
206,852 Common Stock
Mar 14 2025
SELL
Payment of exercise price or tax liability
$9,007 $3.59 p/Share
2,509 Reduced 1.23%
201,252 Common Stock
Mar 14 2025
BUY
Exercise of conversion of derivative security
-
8,334 Added 3.93%
203,761 Common Stock
Mar 03 2025
SELL
Payment of exercise price or tax liability
$80,735 $4.04 p/Share
19,984 Reduced 9.28%
195,427 Common Stock
Mar 03 2025
BUY
Exercise of conversion of derivative security
-
59,999 Added 21.79%
215,411 Common Stock
Dec 16 2024
SELL
Payment of exercise price or tax liability
$29,470 $7.84 p/Share
3,759 Reduced 2.36%
155,412 Common Stock
Dec 16 2024
BUY
Exercise of conversion of derivative security
-
8,334 Added 4.98%
159,171 Common Stock
RKP

Raj K. Puri

Chief Regulatory Officer
San Carlos, CA

Track Institutional and Insider Activities on IOVA

Follow IOVANCE BIOTHERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IOVA shares.

Notify only if

Insider Trading

Get notified when an Iovance Biotherapeutics, Inc. insider buys or sells IOVA shares.

Notify only if

News

Receive news related to IOVANCE BIOTHERAPEUTICS, INC.

Track Activities on IOVA